Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin

J Clin Oncol. 2019 Jan 10;37(2):171-173. doi: 10.1200/JCO.18.01398. Epub 2018 Nov 15.

Authors

Shaji K Kumar¹, Morie A Gertz¹, Angela Dispenzieri¹

Affiliation

¹ Shaji K. Kumar, MD; Morie A. Gertz, MD; and Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN.

PMID: 30433848
DOI: 10.1200/JCO.18.01398

No abstract available

Publication types

Letter
Validation Study

MeSH terms

Biomarkers / blood
Cardiomyopathies / blood
Cardiomyopathies / diagnosis*
Cardiomyopathies / immunology
Humans
Immunoglobulin Light Chains / blood
Immunoglobulin Light-chain Amyloidosis / blood
Immunoglobulin Light-chain Amyloidosis / diagnosis*
Immunoglobulin Light-chain Amyloidosis / immunology
Natriuretic Peptide, Brain / blood
Peptide Fragments / blood
Predictive Value of Tests
Prognosis
Reproducibility of Results
Severity of Illness Index
Troponin T / blood*

Substances

Biomarkers
Immunoglobulin Light Chains
Peptide Fragments
Troponin T
pro-brain natriuretic peptide (1-76)
Natriuretic Peptide, Brain